Advertisement
Screener

TEMA ETFS LLC Historic Quarter Change: USA Other Stocks, Sold Out

TEMA ETFS LLC historic quarter change: USA Other Stocks, Sold out

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 6 quarters from 2024-12-31 to 2026-06-30, TEMA ETFS LLC opened 2 positions, added to 1, reduced 2 and sold out of 7.

  • Q2 2026: Stock DUPONT DE NEMOURS INC; Country of operation United States; Class COM; Shares before 9,454.
  • Q4 2025: Stock AMCOR PLC; Country of operation —; Class ORD; Shares before 40,619.
  • Q2 2025: Stock BLUEPRINT MEDICINES CORP; Country of operation United States; Class COM; Shares before 20,972.
  • Q1 2025: Stock SPRINGWORKS THERAPEUTICS INC; Country of operation —; Class COM; Shares before 30,811.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 2056807), 6 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-07-10); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-04-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-01-16); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-10-24); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-13); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2024-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2026DUPONT DE NEMOURS INC
CUSIP 26614N102
United StatesCOM9,4540-9,454$432,993$0-$432,9932026-07-10
Q4 2025AMCOR PLC
CUSIP G0250X107
ORD40,6190-40,619$332,263$0-$332,2632026-01-16
Q2 2025BLUEPRINT MEDICINES CORP
CUSIP 09627Y109
United StatesCOM20,9720-20,972$1,856,232$0-$1,856,2322025-08-13
Q1 2025SPRINGWORKS THERAPEUTICS INC
CUSIP 85205L107
COM30,8110-30,811$1,113,201$0-$1,113,2012025-05-14
Q1 2025INARI MED INC
CUSIP 45332Y109
United StatesCOM14,7900-14,790$755,030$0-$755,0302025-05-14
Q1 2025VERVE THERAPEUTICS INC
CUSIP 92539P101
United StatesCOM89,2390-89,239$503,308$0-$503,3082025-05-14
Q1 2025INTRA-CELLULAR THERAPIES INC
CUSIP 46116X101
United StatesCOM3,3880-3,388$282,966$0-$282,9662025-05-14

Similar Firms

Firm NameCountry13F ValueHoldings
UHLMANN PRICE SECURITIES, LLCUnited States$1.489B254
Plato Investment Management LtdAustralia$1.489B516
NEXPOINT ASSET MANAGEMENT, L.P.United States$1.491B123
RUSH ISLAND MANAGEMENT, LPUnited States$1.491B22
Lutz Financial Services LLCUnited States$1.488B100
ARMSTRONG ADVISORY GROUP, INCUnited States$1.491B959
Angeles Investment Advisors, LLCUnited States$1.488B31
Quintet Private Bank (Europe) S.A.Luxembourg$1.492B187
FIRST AMERICAN TRUST, FSBUnited States$1.487B465
OAK ASSOCIATES LTD /OH/United States$1.486B140